retatrutide liver enzymes Diagram showing the mechanism of action of Triple hormone receptor agonist retatrutide

While microneedle patches and advanced delivery technologies are under investigation in preclinical and early clinical studies, no products have completed the FDA approval process

However, some patients may continue to experience persistent symptoms that necessitate dose adjustment or treatment discontinuation

Ready to Start Your Weight Loss Journey

Clinical and real-world trials suggest differences in weight-loss results between oral GLP-1s and injections, but the medications biological effects are only part of the equation

Consult a Medical Professional If youve taken the product and feel unwell, consult your doctor immediately

Important safety note for people with diabetes: If you are taking insulin or a sulfonylurea alongside any investigational glucose-lowering therapy, improvements in blood glucose control may increase the risk of hypoglycaemia